Design, execute, develop, and optimize upstream process for biosimilars monoclonal antibodies, fusion proteins in CHO Cells. R&D USP Mammalian, R&D Analytical, R&D Bioassay
Bachelor degree in Pharma or Life Science. pharmaceutical sales experience, preferably with diabetes products. Consistent record of meeting or exceeding sales targets
Facilitate and manage corporate quality audits and regulatory audits and drive the Supplier Qualification Program, including the identification, evaluation through audits, monitoring, maintenance, and re-qualification of vendors.
The position requires knowledge of cGMPs, applicable global regulatory manufacturing guidance, and the corporate/industry standards. The position requires working cross-functionally within the site and other functions to deliver on technical objectives.
A fixed monthly amount shall be admissible, arrived by deducting the basic pension from the pay drawn at the time of retirement & as Transportation Allowance as admissible. The amount of remuneration so fixed shall remain unchanged for the term of contract.
M.Sc / M.Tech. in any branch of Biology or M.Sc. in Natural or Agricultural Sciences from a recognized university, with at least two years of research experience in academia or industry.
Proven track record of leading a large, geographically diverse sales team, including at least 2 years of experience overseeing half of India with consistent performance, growth and positive P&L outcome.
The U.S. Food and Drug Administration today approved a new indication for Breyanzi (Lisocabtagene maraleucel) as the first Chimeric Antigen Receptor (CAR) T-cell therapy in the U.S. for treatment of adults with marginal zone lymphoma (MZL) who have failed treatment with or relapsed after two or more prior lines of therapy.